[1]. Ren X, Pan X, Zhang Z, Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against
5-trimethylsila...
1207351-08-3
~%
4-甲基-N-[4-[(4-甲...
1257628-77-5
CAS号1207351-08-35-trimethylsila...
陕西缔都医药有限责任公司
联系商家时请提及chemicalbook,有助于交易顺利完成!